Skip to main content

U.S. May Be Able to Produce Its Own Medical Isotopes at the Clinton Nuclear Power Station

The NRC just approved a license amendment at the Clinton nuclear plant in Illinois for a pilot program “to explore the production of Cobalt-60… Cobalt-60 is a radioactive material licensed by the NRC for applications such as commercial irradiators and cancer treatment.”

As you may or may not know, there is a medical isotope shortage in the world because the reactor that produces 30-40% of the isotopes (Chalk River) is shut down. This has opened up a large opportunity to see if other suppliers can fill the gap, especially in the U.S. since we don’t have our own commercial isotope production facilities.

NRC:

The amended license allows Exelon to alter the reactor’s core by inserting up to eight modified fuel assemblies containing rods filled with Cobalt-59, which would absorb neutrons during reactor operation and become Cobalt-60. The pilot program will provide data on how the modified assemblies perform during reactor operation. Exelon has informed the NRC it plans to insert the modified assemblies during Clinton’s current refueling outage.

The NRC staff approved the amendment after evaluating the potential effects of the modified fuel assemblies on plant operation and accident scenarios.

If this program is successful, basically every reactor in the U.S. could become a medical isotope producer. Not only would nuclear plants be providing an essential commodity to our society (electricity), but they would also be saving lives. Pretty exciting stuff.

Update, 1/19, 2:00 pm: Here are a few interesting stats from GE Hitachi who's teaming up with Exelon to test the program:

The International Irradiation Association estimates that 15 million cancer treatments are carried out using cobalt-60 each year in hospitals and clinics in over 80 countries. More than 500,000 brain cancer treatments have been performed using cobalt-60.
...
In addition to cancer treatment, cobalt-60 is used to preserve food, decontaminate packaging materials, sanitize cosmetics and purify pharmaceuticals. More than 40 percent of U.S.-manufactured medical devices, including syringes and bandages, are cleaned and/or sterilized using cobalt-60.

Comments

Anonymous said…
If this program is successful, basically every reactor in the U.S. could become a medical isotope producer.

Has there been even the slightest indication of such interest by other US power reactor operators? this is just your hyperbole, right?

Is the isotopes market large enough to sustain production from 104 US power reactors? or even half of them?
David Bradish said…
If you read carefully what I wrote, I didn't say it would be economical for all reactors to do this, only that it is possible. One reactor supplies 30-40% of the isotopes in the world. Thus, Clinton and other nuclear plants would be competing in a small market like you point out.

Just speculating here but sometime in the future, we could discover another need for the isotopes because we've lowered its price through competition. The point of the post was to highlight another diverse feature nuclear energy has to offer.
Anonymous said…
Most plants have gone to great lengths to remove every possible source of Co-60 from their cores, to reduce personnel dose. One notable example would be Stellite pins and rollers in BWR control blades, which tended to get very hot by the time you wanted to swap old blades for new. Of course, in this proposed scheme for Clinton, the cobalt would be well sealed in the dummy bundles, so maybe it's not such a problem.

This might be a perfect thing to do at Cooper station if they still have dummy bundles in their core. They already have experience designing and operating reactor cores including inert bundles that do nothing but parasitically absorb neutrons.
Anonymous said…
Cobalt 60 is also used a gamma source for industrial radiography (of welding that is over 2 inches thick; not mentioned in the article).

Popular posts from this blog

Fluor Invests in NuScale

You know, it’s kind of sad that no one is willing to invest in nuclear energy anymore. Wait, what? NuScale Power celebrated the news of its company-saving $30 million investment from Fluor Corp. Thursday morning with a press conference in Washington, D.C. Fluor is a design, engineering and construction company involved with some 20 plants in the 70s and 80s, but it has not held interest in a nuclear energy company until now. Fluor, which has deep roots in the nuclear industry, is betting big on small-scale nuclear energy with its NuScale investment. "It's become a serious contender in the last decade or so," John Hopkins, [Fluor’s group president in charge of new ventures], said. And that brings us to NuScale, which had run into some dark days – maybe not as dark as, say, Solyndra, but dire enough : Earlier this year, the Securities Exchange Commission filed an action against NuScale's lead investor, The Michael Kenwood Group. The firm "misap...

Wednesday Update

From NEI’s Japan micro-site: NRC, Industry Concur on Many Post-Fukushima Actions Industry/Regulatory/Political Issues • There is a “great deal of alignment” between the U.S. Nuclear Regulatory Commission and the industry on initial steps to take at America’s nuclear energy facilities in response to the nuclear accident in Japan, Charles Pardee, the chief operating officer of Exelon Generation Co., said at an agency briefing today. The briefing gave stakeholders an opportunity to discuss staff recommendations for near-term actions the agency may take at U.S. facilities. PowerPoint slides from the meeting are on the NRC website. • The International Atomic Energy Agency board has approved a plan that calls for inspectors to evaluate reactor safety at nuclear energy facilities every three years. Governments may opt out of having their country’s facilities inspected. Also approved were plans to maintain a rapid response team of experts ready to assist facility operators recoverin...

Nuclear Utility Moves Up in Credit Ratings, Bank is "Comfortable with Nuclear Strategy"

Some positive signs that nuclear utilities can continue to receive positive ratings even while they finance new nuclear plants for the first time in decades: Wells Fargo upgrades SCANA to Outperform from Market Perform Wells analyst says, "YTD, SCG shares have underperformed the Regulated Electrics (total return +2% vs. +9%). Shares trade at 11.3X our 10E EPS, a modest discount to the peer group median of 11.8X. We view the valuation as attractive given a comparatively constructive regulatory environment and potential for above-average long-term EPS growth prospects ... Comfortable with Nuclear Strategy. SCG plans to participate in the development of two regulated nuclear units at a cost of $6.3B, raising legitimate concerns regarding financing and construction. We have carefully considered the risks and are comfortable with SCG’s strategy based on a highly constructive political & regulatory environment, manageable financing needs stretched out over 10 years, strong partners...